ACCIPITER CAPITAL MANAGEMENT, LLC Q3 2018 significant ownership

ACCIPITER CAPITAL MANAGEMENT, LLC is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

ACCIPITER CAPITAL MANAGEMENT, LLC Q3 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
TRIPLE-S MANAGEMENT CORP	April 28, 2014	118,172	4.3%
ORCHID CELLMARK INC	May 06, 2011	1,581,113	5.3%
NightHawk Radiology Holdings Inc^{Sold out}	February 16, 2010	0	0.0%
YM BIOSCIENCES INC^{Sold out}	February 16, 2010	0	0.0%
RURAL/METRO CORP /DE/	January 06, 2010	461,351	1.8%
IMPAX LABORATORIES INC	June 30, 2009	140,385	0.2%
ATHERSYS, INC / NEW	February 17, 2009	365,132	1.9%
ATS MEDICAL INC	February 17, 2009	1,161,557	1.6%
EMAGEON INC	February 17, 2009	1,098,984	5.1%
HI TECH PHARMACAL CO INC^{Sold out}	February 17, 2009	0	0.0%
MERIT MEDICAL SYSTEMS INC^{Sold out}	February 17, 2009	0	0.0%
Northstar Neuroscience, Inc.^{Sold out}	February 17, 2009	0	0.0%
Transcept Pharmaceuticals Inc	February 17, 2009	166,760	1.3%
TRIMERIS INC^{Sold out}	February 17, 2009	0	0.0%
AMAG PHARMACEUTICALS INC.	June 05, 2008	67,421	0.4%
PENWEST PHARMACEUTICALS CO	March 14, 2008	263,932	1.4%
VISTACARE, INC.	March 06, 2008	?	?
NOVACEA INC	February 14, 2008	783,589	3.1%
Skilled Healthcare Group, Inc.	February 14, 2008	43,169	0.2%
BTHC VI Inc	June 18, 2007	398,125	2.1%
Emergency Medical Services CORP	January 18, 2007	19,718	0.2%
Valera Pharmaceuticals Inc	December 13, 2006	262,036	1.8%
AMERICAN HOMEPATIENT INC	October 05, 2006	?	?
CYNOSURE INC	February 09, 2006	122,583	2.5%
ARENA PHARMACEUTICALS INC^{Sold out}	September 21, 2005	0	0.0%

Compare quarters

Export ACCIPITER CAPITAL MANAGEMENT, LLC's holdings